Does combined therapy of Ca-channel blocker and angiotensin converting enzyme inhibitor exceed monotherapy in renal protection against hypertensive injury in rats?

Clinical and Experimental Hypertension

Volumn 18, Issue 2, 1996, Pages 243-256

  Kanno, Yoshihiko ^a   Okada, Hirokazu ^a   Suzuki, Hiromichi ^a   Ikenaga, Hideki ^a   Ishii, Naohito ^b   Itoh, Hajime ^b   Saruta, Takao ^a  

^a KEIO UNIVERSITY   (Japan)

^b KITASATO UNIVERSITY   (Japan)

Author keywords

combination therapy; renal protection; SHR

Indexed keywords

AMLODIPINE; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; ENDOGENOUS COMPOUND;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; HYPERTENSION; KIDNEY INJURY; NONHUMAN; ORAL DRUG ADMINISTRATION; PROTEIN URINE LEVEL; RAT; SALT LOADING; SODIUM RETENTION; SPONTANEOUSLY HYPERTENSIVE RAT;

EID: 0029878921     PISSN: 10641963     EISSN: None     Source Type: Journal    
DOI: 10.3109/10641969609081767     Document Type: Article

References (25)

1. Weir MR: Hypertensive nephropathy: Is a more physiologic approach to blood pressure control an important concern for the preservation of renal function? Am J Med 1992, 93(suppl 2A):27S-37S.
2. 1992 Joint National Committee: The Fifth report of the Joint National Committee on Detection, evaluation, and treatment of high blood pressure Arch Int Med 1993, 153:154-183.
3. Stornello M, Valvo EV, Scapellato L: Hemodynamic, renal, and humoral effects of the calcium entry blocker nicardipine and converting enzyme inhibitor captoril in hypertensive type II diabetic patients with nephrology J Cardiovasc Pharmacol 1989, 14:851-855.
4. Wenzel U, Helmchen U, Schoeppe W, Schwietzer G: Combination treatment of enalapril with nitrendipine or in rats with renovascular hypertension Hypertension 1994, 23:114-122.
5. Dworkin LD, Feiner HD, Parker M, Tolbert E: Effects of nifedipine and enalapril on glomerular structure and function in uninephrectomized SHR. Kidney Int 1991, 39:1112-1117.
6. Burges RA, Gardiner DG, Carter AJ, Mckay FF: Long term natriuretic and antihypertensive activity in spontaneous hypertensive rats with developing and established hypertension. Ann. N.Y. Acad. Sci. 1988, 522:516-8.
7. Terzi F, Beaufils H, Laouari D, Burtin M, Kleinknecht C: Renal effect of antihypertensive drugs depends on sodium diet in the excision remnant kidney model Kidney Int 1992, 42:354-363.
8. Pfeffer JM, Pfeffer MA, Frohlich ED: Validity of an indirect tail-cuff method for determining systolic arterial pressure in unanesthetized normotensive and spontaneously hypertensive rat. J. Lab. Clin. Mod. 1971, 78:957-962.
9. Peterson GL: A simplification of the protein assay method of Lowry et al. Which is more generally applicable. Anal. Biochem. 1977, 83:346-356.
10. Ikenaga H, Suzuki H, Ishii N, Itoh H, Saruta T: Role of NO on pressure-natriuresis in Wistar-Kyoto and spontaneously hypertensive rats Kidney Int 1993, 43:205-211.
11. Okada H, Suzuki H, Konishi K, Sakaguchi H, Saruta T: Histological alterations in renal specimens as indicators of prognosis of IgA nephropathy. Clin Nephrol 1992, 37:235-238.
12. Wallenstein S, Zucker CL, Fleiss J: Some statistical methods useful on circulation research Circ Res 1980, 47:1-9.
13. Guazzi MD, De Cesare N, Galli C, Salvioni A, Tramontana C, Tamborini G, Bartorelli A: Calcium- channel blockade with nifedipine and angiotensin converting-enzyme inhibition with captopril in the therapy of patients with severe primary hypertension Circulation 1984, 70:279-284.
14. Anderson A, Morgan T: Interaction of enalapril with sodium restriction, diuretics, and slow-channel-calcium-blocking drugs Nephron 1990, 55 (suppl. l):70-72.
15. Glorioso N, Manunta P, Troffa C, Pazzola A, Soro A, Pala F, Meris MG, Madeddu P, Tonolo G: Effects of nitrendipine on blood pressure, renin-angiotensin system, and kidney function in essential hypertension J Cardiovasc Pharmacol 1988, 12(suppl 4):S142-S145.
16. Kureya P, Beevers DG: The mechanisms of hypertension and the role of ACE inhibitors J Hum Hypertens 1991, 5:3-8.
17. Reams GP, Lau A, Hamony A, Bauer H: Amlodipine therapy corrects renal abnormalities encountered in hypertensive state. Am J Kidney Dis 1987, 10:446-451.
18. Loutzenhiser RD, Epstein M, Fischetti F, Horton C: Effects of amlodipine on renal hemodynamics. Am J Cardiol 1989, 64:1221-1281.
19. Jackson B, Johnston CI: The contribution of systemic hypertension to progression of chronic renal failure in the rat remmnant kidney: effect of treatment with an angiotensin converting enzyme inhibitor or a calcium inhibitor J Hypertens 1988, 6:495-501.
20. Brunner FP, Thiel G, Hermle M, Bock A, Mihatsch MJ: Long-term enalapril and verapamil in rats with reduced renal mass Kidney Int 1989, 36:969-977.
21. Ulm EH, Hichens M, Gomez HJ, Till AE, Hand E, Vassil TC, Biollaz J, Brunner HR, Schelling JL: Enalapril maleate and a lysine analogue (MK-521) disposition in man Br J Clin Pharmac 1982, 14:357-362.
22. Burges RA, Dodd MG: Amlodipine Cardiovascular Drug Reviews 1990, 8:25-44.
23. Marre M: Microalbuminuria and ACE inhibition in non-hypertensive diabetics J Diabetic Complications 1990, 4:84-5.
24. Brunner HR, Menard J, Waeber B, Burnier M, Biollaz J, Nussberger J, Bellet M: Treating the individual hypertensive patient:considerations on dose, sequential monotherapy and drug combinations J Hypertens 1990, 8:3-11.
25. Frohlich ED, Chien Y, Sesoko S, Pegram BL: Relationship between dietary sodium intake, hemodynamics, and cardiac mass in SHR and WKY rats Am J Physiol 1993, 264:R30-R34.